Xiao-Ling Zhu Selected Research

Postoperative Hemorrhage

1/2021

An Optimized Enhanced Recovery After Surgery (ERAS) Pathway Improved Patient Care in Adolescent Idiopathic Scoliosis Surgery: A Retrospective Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Ling Zhu Research Topics

Disease

3	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 01/2016
2	Proteinuria 11/2018 - 12/2013
2	Reperfusion Injury 01/2017 - 01/2009
2	Myocardial Infarction 04/2008 - 05/2007
2	Neoplasms (Cancer) 07/2007 - 05/2007
1	Pain (Aches) 01/2021
1	Postoperative Pain 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Scoliosis 01/2021
1	Postoperative Hemorrhage 01/2021
1	Obesity 12/2020
1	Hyperplasia 12/2019
1	Neointima 12/2019
1	Inflammation (Inflammations) 01/2019
1	Spinal Cord Ischemia 01/2017
1	Gingivitis 11/2016
1	Acute Lung Injury 01/2016
1	IGA Glomerulonephritis (IGA Nephropathy) 04/2015
1	Lung Neoplasms (Lung Cancer) 01/2014
1	No-Reflow Phenomenon 01/2013
1	ST Elevation Myocardial Infarction 01/2013
1	Chronic Renal Insufficiency 05/2011
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2009
1	Brain Ischemia (Cerebral Ischemia) 01/2009
1	Stroke (Strokes) 01/2009
1	Hypertrophy 06/2008
1	Aggressive Periodontitis (Periodontosis) 05/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2007
1	Inferior Wall Myocardial Infarction 05/2007

Drug/Important Bio-Agent (IBA)

1	GlucocorticoidsIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Phosphodiesterase InhibitorsIBA 01/2021
1	SmokeIBA 01/2021
1	Vitamin D FDA LinkGeneric 12/2020
1	hydroxide ionIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Circular RNAIBA 12/2019
1	Neuropilin-1IBA 12/2019
1	Cannabinoid Receptor AgonistsIBA 01/2019
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2019
1	CreatinineIBA 11/2018
1	NitrogenIBA 11/2018
1	Urea (Carbamide)FDA LinkGeneric 11/2018
1	HMGB1 Protein (HMG1)IBA 01/2017
1	lipoxin A4IBA 01/2017
1	sivelestatIBA 01/2016
1	SodiumIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2016
1	Complement C4 (Complement Component 4)IBA 04/2015
1	Insulin-Like PeptidesIBA 01/2014
1	methyl 4-azidophenylacetimidate (APAI)IBA 01/2014
1	ResveratrolIBA 12/2013
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2013
1	Emodin (Archin)IBA 05/2011
1	Messenger RNA (mRNA)IBA 01/2009
1	ThioredoxinsIBA 01/2009
1	tetramethylpyrazineIBA 01/2009
1	Thioredoxin Reductase 1IBA 01/2009
1	Protein Kinase CIBA 06/2008
1	Rosiglitazone (Avandia)FDA Link 06/2008
1	maltoporinsIBA 06/2008
1	Peroxisome ProliferatorsIBA 06/2008
1	Endothelin-1 (Endothelin 1)IBA 06/2008
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2007
1	Glycoproteins (Glycoprotein)IBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2007
2	Percutaneous Coronary Intervention 01/2013 - 05/2007
1	Enhanced Recovery After Surgery 01/2021
1	Length of Stay 01/2021
1	Catheters 01/2017
1	Electroacupuncture 01/2017
1	Aftercare (After-Treatment) 11/2016
1	Drug Therapy (Chemotherapy) 05/2007
1	Thrombectomy 05/2007